As a nuclear medicine technologist, you have the power to capture not only how organs and tissues look, but also how they work. In this program, you'll learn to safely and compassionately administer radioactive drugs, or radiopharmaceuticals, to patients and obtain rapid-succession images where they concentrate in the body, so that you can assist physicians in detecting, and even treating, certain medical conditions.
During the third year, the professional phase of the program, you'll follow a synchronous distance/online class schedule, which means that you will log and call in during specific class times. This schedule offers you the flexibility of an online education. You'll participate in clinical experiences at sites predetermined by your specific location, where you'll work alongside industry experts and gain firsthand knowledge of what it's like to be a nuclear medicine technologist.
The accelerated time frame of 36 months gives you the benefit of an immersive education while preparing you for your career faster. When you graduate, you'll be eligible to sit for registration by the American Registry of Radiologic Technologists and the Nuclear Medicine Technology Certification Board. And you'll be fully prepared to become a leader. |
These courses are intended as guidelines. Speak to your guidance counsellor to see what courses are offered at your school.
See website for admission requirements. |
| Test Scores: | - or Scholastic Aptitude Test
- Test of English as a Foreign Language (Paper Based) [min. 550] or International English Language Testing System (academic or immigration) [min. ] or Test of English as a Foreign Language (Internet Based) [min. 79]
|
| Additional Admission Requirements: | - Letter(s) of Reference
- Statement of Research Interests
|
* We make every attempt to provide accurate information on prerequisites, programs, and tuition. However, this information is subject to change without notice and we highly recommend that you contact the school to confirm important information before applying.
